Quick Answer
OptimizeRx Corp reported Stockholders Equity of $128.29 million for fiscal year 2025.
OptimizeRx Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $128.29M | +9.7% |
| 2024 | $117.00M | -7.6% |
| 2023 | $126.55M | +0.4% |
| 2022 | $126.11M | -4.0% |
| 2021 | $131.38M | +162.9% |
| 2020 | $49.97M | +11.4% |
| 2019 | $44.86M | +143.0% |
| 2018 | $18.46M | +196.7% |
| 2017 | $6.22M | -20.4% |
| 2016 | $7.81M | -12.6% |
| 2015 | $8.94M | +94.0% |
| 2014 | $4.61M | +176.4% |
| 2013 | $1.67M | +18.7% |
| 2012 | $1.40M | -11.6% |
| 2011 | $1.59M | -16.1% |
| 2010 | $1.89M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $122.26M | +6.8% | +2.5% |
| June 30, 2025 | $119.28M | -1.4% | +2.6% |
| March 31, 2025 | $116.27M | -5.1% | -0.6% |
| December 31, 2024 | $117.00M | -7.6% | +2.2% |
| September 30, 2024 | $114.47M | -1.4% | -5.4% |
| June 30, 2024 | $121.02M | +4.5% | -1.2% |
| March 31, 2024 | $122.54M | -1.2% | -3.2% |
| December 31, 2023 | $126.55M | +0.4% | +9.0% |
- OptimizeRx Corp showed an increase of +9.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, OptimizeRx Corp’s stockholders equity has grown by 6674.4% (from $1.89 million to $128.29 million).
- The most recent figure is from OptimizeRx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: